Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07088783

Mobile App Education Based on Orem's Self-Care Model in Multiple Myeloma Patients

This randomized controlled trial aims to assess the effectiveness of a mobile application-based education program, developed according to Orem's Self-Care Model, in improving self-care agency and quality of life among patients with multiple myeloma in Turkey. Participants are recruited from the outpatient clinic of a hospital and randomly assigned to either the intervention or control group. The intervention group uses the mobile application for 24 weeks, while the control group continues with routine care and receives a standard one-page brochure commonly distributed to cancer patients. All participants complete a demographic form, the EORTC QLQ-C30, QLQ-MY20, and the Self-Care Agency Scale at baseline, week 12, and week 24. The collected data will be used to compare changes in self-care agency and quality of life between the two groups over time.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

About this study

This study was conducted to address the self-care needs of patients diagnosed with multiple myeloma, a chronic and complex hematologic cancer. Based on Orem's Self-Care Deficit Nursing Theory, a mobile application was developed to improve patients' self-care agency and quality of life. The intervention group uses the mobile application for 24 weeks, which includes educational content, self-monitoring features, and motivational messages. The control group receives routine care, which includes standard medical follow-up and a one-page general information brochure commonly provided to cancer patients at the hospital. Self-care agency and quality of life are assessed using the Self-Care Agency Scale, EORTC QLQ-C30, and EORTC QLQ-MY20 at three time points: baseline, week 12, and week 24. The results are expected to contribute to evidence-based self-care interventions for patients with hematologic malignancies.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed with multiple myeloma and received at least one course of treatment
  • Age 18 or older
  • Able to speak and read Turkish
  • ECOG performance status of I, II, or III
  • Has used at least one Android-based digital tool (e.g., sending text messages, email, using mobile apps)
  • Literate (able to read and write)
  • Willing to participate and able to provide written informed consent

Exclusion criteria

  • Not currently diagnosed with multiple myeloma
  • Has cognitive or psychological disorders that prevent completing questionnaires or using the mobile application
  • Unable to speak or understand Turkish
  • Unwilling or unable to provide written informed consent

Treatment and study plan

Mobile App Education

Behavioral

A 24-week self-care education delivered via a mobile application based on Orem's Self-Care Model

Primary outcomes

  1. Change in Self-Care Agency Score

    Time frame: Baseline, 12th week, and 24th week

    Self-care agency was assessed using the Self-Care Agency Scale.

Sponsors and collaborators

Lead sponsor

Ozlem

Other

Collaborators

  • Dokuz Eylul University

Registry information

Official study title

The Effect of Mobile Application-Based Education Developed According to Orem's Self-Care Model on Enhancing Self-Care Agency in Patients With Multiple Myeloma: A Randomized Controlled Trial

Acronym: OCARE-MM

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jul 28, 2025
Registry last updated
Jul 28, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.